Anzeige
Mehr »
Mittwoch, 11.02.2026 - Börsentäglich über 12.000 News
Drohnen, Robotik, E-Autos: Diese Hightech-Aktie könnte jetzt zünden
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
515 Leser
Artikel bewerten:
(2)

Smartee Denti-Technology: Smartee Empowers the Next Generation of Orthodontists at the 2nd HADO Exhibition

BUDAPEST, Hungary, May 22, 2024 /PRNewswire/ -- OnMay 20, 2024, Smartee Denti-Technology, a global leader in clear aligners and digital orthodontic solutions, presented its innovative Smartee GS Mandibular Repositioning Technology at the 2nd HADO Exhibition, held from May 16-19, 2024 in Budapest.

The HADO exhibition serves as a platform for sharing advanced orthodontic practices and perspectives

The Hungarian Association for Dentofacial Orthopedics and Orthodontics (HADO) Exhibition serves as a platform for sharing advanced orthodontic practices and perspectives among orthodontists from all over the world. With over 300 attendees and partners, 32+ hours of intensive learning, and 4 days of professional experience sharing, the event fostered a culture of continuous learning in the orthodontic community.

Smartee booth attracted a steady stream of visitors eager to explore Smartee's unique innovations and solutions

During the exhibition, the Smartee booth attracted a steady stream of visitors eager to explore Smartee's unique innovations and solutions, particularly the Smartee GS mandibular repositioning solutions of S8, S9, S10, and S11. Smartee's commitment to innovation and excellence in orthodontic care resonates deeply with HADO's mission to empower the next generation of orthodontic professionals.

Prof. Gang Shen from Taikang Bybo, Smartee's Chief Scientist in R&D, was invited by HADO to deliver a keynote lecture titled "The Clear S8 Orthopedic Therapy: Fundamental Mechanisms, Therapeutic Procedures, and Clinical Efficacy." Prof. Gang Shen's presentation provided attendees with invaluable insights into a non-invasive approach for treating severe Class II malocclusion, addressing a pressing challenge in the current orthodontic field.

Prof. Gang Shen, Smartee's Chief Scientist in R&D, was invited by HADO to deliver a keynote lecture

Prof. Gang Shen's presentation provided attendees with invaluable insights into a non-invasive approach for treating severe Class II malocclusion, addressing a pressing challenge in the current orthodontic field.

Reflecting on Smartee's contribution, Dr. Felkai, Vice President of HADO, remarked, "Smartee clear aligners offer a blend of effectiveness in correcting malocclusion, comfort during wear, unique solutions and customization options. I'm particularly intrigued by Smartee's GS mandibular repositioning technology, which holds promise for addressing severe Class II malocclusions, also after the end of growth. On behalf of HADO, I look forward to welcoming more innovative orthodontic solution providers to future events."

Dr. Felkai, Vice President of HADO, and Prof. Gang Shen discuss Smartee's mandibular repositioning technology with participating doctors.

Smartee's participation underscores its dedication to empowering doctors and orthodontists with cutting-edge technologies and comprehensive support. With its series of unique solutions S1-S20, Smartee continues expanding its portfolio and has launched over 10 aligner products catering to different malocclusion problems for children, adolescents, and adults.

For further information, please visit https://smarteealigners.com/

About Smartee Denti-Technology:

Founded in 2004, Smartee is the leading provider of clear aligners and digital orthodontic solutions in China. Headquartered in Shanghai, Smartee has two research & development centers and manufacturing plants that are fully automated. By serving over 64,000 doctors from 48,000 medical institutions in over 47 countries, Smartee has achieved over 1 million perfect smiles worldwide.

With the advance of digital solutions, Smartee continues expanding its portfolio and has launched over 10 aligner products catering to different malocclusion problems for children, adolescents and adults. Collaborating with Prof Gang Shen and his Orthodontic Team, Smartee has developed an innovative product: Smartee GS, which provides orthodontists with mandibular repositioning technology to treat patients with complex indications including facial prognathism, facial retrognathism and mandibular deviation more effectively.

Photo - https://mma.prnewswire.com/media/2419359/1.jpg
Photo - https://mma.prnewswire.com/media/2419360/2.jpg
Photo - https://mma.prnewswire.com/media/2419358/3.jpg
Photo - https://mma.prnewswire.com/media/2419361/4.jpg
Photo - https://mma.prnewswire.com/media/2419362/5.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/smartee-empowers-the-next-generation-of-orthodontists-at-the-2nd-hado-exhibition-302153014.html

© 2024 PR Newswire
Favoritenwechsel
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.